Media Thread, page-13716

"You were expecting commercialisation when HER-Vaxx wasn't even close to Ph1 clinical trial completion???"

WTF are you talking about? Her-Vaxx was a Phase II trial comparing Her-vaxx + chemo to chemo alone. IMU decided to stop recruiting at 34 of the planned 68 patients on advice from its own "Independent Data Monitoring Committee" for NEVER EXPLAINED "ethical reasons". Apparently, so good were the results after just 34 patients, that Leslie started with the dance cards full commentary at that time.

Maybe she was knowingly making overly-exhuberant statements. Maybe she genuinely believed BP would be interested just on the basis of the 17 individuals that had been given Her-Vaxx at that point. Either way, its a massive fail as CEO.

Of course, we all found out the hard way that the trial was stopped for commercial reasons. After three years, it had only recruited 50% of the patients by end-2020 (which was the "original, revised, revised" date for its completion). Its results were not strong enough to achieve its objective of becoming the SOC (with chemo), so IMU decided to announce it would try it in trials with three other combinations. One of these took off and crashed after just a handful of patients were recruited, two never took off at all.

No bruh, I'm not clueless. You?


".... so if HER-Vaxx (still need more clinical data)"

Which is coming from where? There is not a trial anywhere in the world in which patients are being administered Her-Vaxx.

Maybe less posting, more reading?